Surge in Pharma Sales Driven by Demand
The Indian pharmaceutical retail market has experienced a significant turnaround in November, driven by a surge in demand for dermatological and cardiac medications. After several months of sluggish sales, the market has rebounded, showcasing double-digit growth. This resurgence can be attributed to various factors, including increased pollution levels in many regions, which have notably boosted the sales of respiratory medications like Foracort. According to data from IQVIA, Foracort emerged as the top-selling drug in November, marking a pivotal moment for the industry.
Strong Performance of Key Medications
In November, Foracort, a medication primarily used for asthma and other respiratory issues, led the market with impressive sales of ₹82 crore. This represented a 2% growth compared to previous months. Following closely was Augmentin, an antibiotic that recorded sales of ₹76 crore, reflecting a 9% increase. Glycomet GP, an antidiabetic therapy, held the third position with sales of ₹69 crore, remaining relatively stable. The performance of these medications highlights the shifting dynamics within the pharmaceutical sector, where specific therapies are gaining traction.
The overall market saw a notable rise in various therapeutic segments. Urology led the charge with an 18% increase, while dermatology, cardiology, and pain relief therapies followed closely with growth rates of 16%, 13%, and 13%, respectively. Notably, pain relief medication Zerodol SP achieved a remarkable 22% growth. Other medications that experienced over 20% growth included Ryzodeg, Rosuvas, Cilacar, Rybelsus, and Duphalac. This diverse range of successful products indicates a robust recovery in the pharmaceutical market.
Market Leaders and Competitive Landscape
Sun Pharma has solidified its position as a market leader, holding an 8% share in the overall pharmaceutical retail market, which is valued at ₹2,28,059 crore. Competitors like Cipla and Dr. Reddy’s have also seen their market shares increase month-on-month. The competitive landscape is evolving, with both domestic companies and multinational corporations (MNCs) reporting positive growth. Domestic firms recorded an impressive growth rate of nearly 11%, while MNCs saw a slightly lower growth rate of just over 10%.
The growth in the market is not limited to specific drug categories. Both acute medications, such as painkillers and anti-infectives, and chronic medications, which are prescribed for long-term health issues, reported double-digit growth of 11% each. This indicates a broad-based recovery across various therapeutic areas, suggesting that the pharmaceutical industry is regaining its footing after a challenging period.
Future Outlook for the Pharmaceutical Market
Looking ahead, analysts predict that the pharmaceutical market will continue to grow at high-single digits through 2025. This growth will likely be driven by price increases and new product launches, although volume growth may remain muted. An analyst from HSBC noted that Indian companies are expected to begin their journey into GLP-1 (Glucagon-like peptide-1) drugs, with the launch of generic liraglutide anticipated in the near future. GLP-1 drugs are crucial for managing blood sugar levels and aiding in weight management.
Globally, MNCs like Novo Nordisk and Eli Lilly have already launched blockbuster drugs targeting obesity and diabetes. These products are expected to enter the Indian market in the coming years, further enhancing the competitive landscape. The pharmaceutical industry is poised for a transformative phase, with innovations and strategic launches likely to shape its future trajectory. As the market adapts to changing consumer needs and regulatory environments, stakeholders must remain agile to capitalize on emerging opportunities.
Observer Voice is the one stop site for National, International news, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.